Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Rakovina Therapeutics Inc. has successfully closed an oversubscribed $3 million private placement, which will accelerate the development of its cutting-edge cancer therapies. The company also announced a partnership with Fairfax Partners Inc. to enhance its market presence and expand its investor base through a comprehensive investor relations program.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue